vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and CENTURY ALUMINUM CO (CENX). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $633.7M, roughly 1.5× CENTURY ALUMINUM CO). Astrana Health, Inc. runs the higher net margin — 0.7% vs 0.3%, a 0.4% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 0.4%). CENTURY ALUMINUM CO produced more free cash flow last quarter ($67.7M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 13.8%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Century Aluminum Company is a US-based producer of primary aluminum, with aluminum plants in Kentucky, South Carolina and Iceland. It is the largest producer of primary aluminum in the United States. The company is a publicly held corporation listed on the NASDAQ. The headquarters is at One South Wacker in Chicago.
ASTH vs CENX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $633.7M |
| Net Profit | $6.6M | $1.8M |
| Gross Margin | — | 13.0% |
| Operating Margin | 1.9% | 5.2% |
| Net Margin | 0.7% | 0.3% |
| Revenue YoY | 42.9% | 0.4% |
| Net Profit YoY | 184.4% | -96.0% |
| EPS (diluted) | $0.12 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $633.7M | ||
| Q3 25 | $956.0M | $632.2M | ||
| Q2 25 | $654.8M | $628.1M | ||
| Q1 25 | $620.4M | $633.9M | ||
| Q4 24 | $665.2M | $630.9M | ||
| Q3 24 | $478.7M | $539.1M | ||
| Q2 24 | $486.3M | $560.8M | ||
| Q1 24 | $404.4M | $489.5M |
| Q4 25 | $6.6M | $1.8M | ||
| Q3 25 | $373.0K | $14.9M | ||
| Q2 25 | $9.4M | $-4.6M | ||
| Q1 25 | $6.7M | $29.7M | ||
| Q4 24 | $-7.8M | $45.2M | ||
| Q3 24 | $16.1M | $47.3M | ||
| Q2 24 | $19.2M | $-2.5M | ||
| Q1 24 | $14.8M | $246.8M |
| Q4 25 | — | 13.0% | ||
| Q3 25 | — | 12.2% | ||
| Q2 25 | — | 5.8% | ||
| Q1 25 | — | 9.6% | ||
| Q4 24 | — | 10.5% | ||
| Q3 24 | — | 15.2% | ||
| Q2 24 | — | 3.6% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | 1.9% | 5.2% | ||
| Q3 25 | 2.0% | 9.2% | ||
| Q2 25 | 3.1% | 3.3% | ||
| Q1 25 | 3.3% | 7.3% | ||
| Q4 24 | 0.1% | 7.8% | ||
| Q3 24 | 5.9% | 11.8% | ||
| Q2 24 | 6.2% | 1.1% | ||
| Q1 24 | 7.5% | 0.4% |
| Q4 25 | 0.7% | 0.3% | ||
| Q3 25 | 0.0% | 2.4% | ||
| Q2 25 | 1.4% | -0.7% | ||
| Q1 25 | 1.1% | 4.7% | ||
| Q4 24 | -1.2% | 7.2% | ||
| Q3 24 | 3.4% | 8.8% | ||
| Q2 24 | 3.9% | -0.4% | ||
| Q1 24 | 3.7% | 50.4% |
| Q4 25 | $0.12 | $0.03 | ||
| Q3 25 | $0.01 | $0.15 | ||
| Q2 25 | $0.19 | $-0.05 | ||
| Q1 25 | $0.14 | $0.29 | ||
| Q4 24 | $-0.14 | $0.58 | ||
| Q3 24 | $0.33 | $0.46 | ||
| Q2 24 | $0.40 | $-0.03 | ||
| Q1 24 | $0.31 | $2.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $134.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $805.6M |
| Total Assets | $2.2B | $2.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $134.2M | ||
| Q3 25 | $463.4M | $151.4M | ||
| Q2 25 | $342.1M | $40.7M | ||
| Q1 25 | $260.9M | $44.9M | ||
| Q4 24 | $290.8M | $32.9M | ||
| Q3 24 | $350.3M | — | ||
| Q2 24 | $327.7M | $41.3M | ||
| Q1 24 | $337.3M | $93.5M |
| Q4 25 | $779.3M | $805.6M | ||
| Q3 25 | $775.5M | $741.8M | ||
| Q2 25 | $765.5M | $724.4M | ||
| Q1 25 | $745.4M | $726.3M | ||
| Q4 24 | $712.7M | $694.4M | ||
| Q3 24 | $704.6M | $628.5M | ||
| Q2 24 | $678.9M | $601.5M | ||
| Q1 24 | $653.5M | $601.5M |
| Q4 25 | $2.2B | $2.3B | ||
| Q3 25 | $2.2B | $2.1B | ||
| Q2 25 | $1.4B | $1.9B | ||
| Q1 25 | $1.3B | $2.0B | ||
| Q4 24 | $1.4B | $1.9B | ||
| Q3 24 | $1.3B | $2.1B | ||
| Q2 24 | $1.3B | $1.8B | ||
| Q1 24 | $1.2B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $102.8M |
| Free Cash FlowOCF − Capex | $-6.0M | $67.7M |
| FCF MarginFCF / Revenue | -0.6% | 10.7% |
| Capex IntensityCapex / Revenue | 0.3% | 5.5% |
| Cash ConversionOCF / Net Profit | -0.44× | 57.11× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $84.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $102.8M | ||
| Q3 25 | $10.0M | $2.0M | ||
| Q2 25 | $90.9M | $7.9M | ||
| Q1 25 | $16.6M | $72.3M | ||
| Q4 24 | $-10.9M | $-41.4M | ||
| Q3 24 | $34.0M | $20.1M | ||
| Q2 24 | $23.2M | $11.5M | ||
| Q1 24 | $6.0M | $-14.8M |
| Q4 25 | $-6.0M | $67.7M | ||
| Q3 25 | $7.4M | $-18.1M | ||
| Q2 25 | $89.5M | $-15.9M | ||
| Q1 25 | $13.6M | $51.1M | ||
| Q4 24 | $-13.5M | $-54.6M | ||
| Q3 24 | $31.7M | $-2.4M | ||
| Q2 24 | $20.4M | $-5.4M | ||
| Q1 24 | $5.6M | $-44.5M |
| Q4 25 | -0.6% | 10.7% | ||
| Q3 25 | 0.8% | -2.9% | ||
| Q2 25 | 13.7% | -2.5% | ||
| Q1 25 | 2.2% | 8.1% | ||
| Q4 24 | -2.0% | -8.7% | ||
| Q3 24 | 6.6% | -0.4% | ||
| Q2 24 | 4.2% | -1.0% | ||
| Q1 24 | 1.4% | -9.1% |
| Q4 25 | 0.3% | 5.5% | ||
| Q3 25 | 0.3% | 3.2% | ||
| Q2 25 | 0.2% | 3.8% | ||
| Q1 25 | 0.5% | 3.3% | ||
| Q4 24 | 0.4% | 2.1% | ||
| Q3 24 | 0.5% | 4.2% | ||
| Q2 24 | 0.6% | 3.0% | ||
| Q1 24 | 0.1% | 6.1% |
| Q4 25 | -0.44× | 57.11× | ||
| Q3 25 | 26.69× | 0.13× | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | 2.43× | ||
| Q4 24 | — | -0.92× | ||
| Q3 24 | 2.11× | 0.42× | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | -0.06× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CENX
| Aluminum | $566.3M | 89% |
| Alumina | $67.4M | 11% |
